Literature DB >> 15582287

Differential regulation of apoptotic cell death in senescent human cells.

Barbara Hampel1, Florence Malisan, Harald Niederegger, Roberto Testi, Pidder Jansen-Dürr.   

Abstract

Aging of human cells can be reproduced in monolayer cultures, revealing the phenotype of replicative senescence. It was shown that diploid human fibroblasts enter a stable growth arrest phenotype at the end of their lifespan and, in particular, these cells are resistant to various apoptotic stimuli. In contrast, human endothelial cells from the umbilical vein (HUVEC) acquire a proapoptotic phenotype when reaching senescence and this probably results from reactive oxygen species (ROS) induced damage and associated signaling. Ceramides were shown to accumulate in senescent fibroblasts and are also known as potent regulators of apoptotic cell death. To further study age-associated changes in proneness to apoptosis between fibroblasts and endothelial cells, both cell types were challenged by administration of exogenous ceramide and apoptotic cell death was determined. While ceramide can efficiently induce apoptosis in both young and senescent cells of either histotype, quantitative evaluation of the data show that senescent fibroblasts are more resistant to apoptosis induction when compared to their young counterparts, whereas in the case of endothelial cells proneness for apoptosis is increased in senescent cells. Together, these data suggest significant differences in the regulation of apoptosis associated with senescence in fibroblasts and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582287     DOI: 10.1016/j.exger.2004.05.010

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  38 in total

Review 1.  Apoptosis and aging: increased resistance to apoptosis enhances the aging process.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2010-11-30       Impact factor: 9.261

2.  Senescent keratinocytes die by autophagic programmed cell death.

Authors:  Karo Gosselin; Emeric Deruy; Sébastien Martien; Chantal Vercamer; Fatima Bouali; Thibault Dujardin; Christian Slomianny; Ludivine Houel-Renault; Fazia Chelli; Yvan De Launoit; Corinne Abbadie
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

Review 3.  Senescence and apoptosis: dueling or complementary cell fates?

Authors:  Bennett G Childs; Darren J Baker; James L Kirkland; Judith Campisi; Jan M van Deursen
Journal:  EMBO Rep       Date:  2014-10-13       Impact factor: 8.807

Review 4.  Cellular senescence: from growth arrest to immunogenic conversion.

Authors:  D G A Burton; R G A Faragher
Journal:  Age (Dordr)       Date:  2015-03-20

Review 5.  Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.

Authors:  Victor J Thannickal; Jeffrey C Horowitz
Journal:  Proc Am Thorac Soc       Date:  2006-06

6.  MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation.

Authors:  Catarina Rippe; Mark Blimline; Katherine A Magerko; Brooke R Lawson; Thomas J LaRocca; Anthony J Donato; Douglas R Seals
Journal:  Exp Gerontol       Date:  2011-10-15       Impact factor: 4.032

Review 7.  Targeting NOX enzymes in pulmonary fibrosis.

Authors:  Louise Hecker; Jeff Cheng; Victor J Thannickal
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

Review 8.  Therapy-induced senescence in cancer.

Authors:  Jonathan A Ewald; Joshua A Desotelle; George Wilding; David F Jarrard
Journal:  J Natl Cancer Inst       Date:  2010-09-21       Impact factor: 13.506

Review 9.  Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.

Authors:  Tanjina Akter; Richard M Silver; Galina S Bogatkevich
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

10.  Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro.

Authors:  M Prencipe; P Fitzpatrick; S Gorman; M Tosetto; M Mosetto; R Klinger; F Furlong; M Harrison; D O'Connor; I B Roninson; J O'Sullivan; A McCann
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.